EDEN PRAIRIE, Minn., Aug. 19, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $12.5 million prior to deducting underwriting […]
Author: Ken Dropiewski
iRhythm Technologies Announces Proposed Public Offering of Common Stock
SAN FRANCISCO, Aug. 18, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today that it has commenced an underwritten public offering of 1,000,000 shares of its common stock. All of the shares in the […]
Children’s Minnesota and Mayo Clinic announce pediatric cardiovascular collaboration
Now one of the largest and strongest pediatric cardiovascular programs in the country MINNEAPOLIS, Aug. 18, 2020 /PRNewswire/ — Children’s Minnesota and Mayo Clinic announced today that they have reached the next phase of an agreement to collaborate in the care of children with congenital heart disease. This phase of the agreement adds pediatric […]
First AngelMed Guardian® Implants in Asia Pacific
EATONTOWN, N.J., Aug. 18, 2020 /PRNewswire/ — Key Highlights: First AngelMed Guardian® patient implants in Asia Pacific for Hydrix Medical, a subsidiary of Hydrix Limited (ASX: HYD) Four implants were carried out under the guidance of leading Cardiologist Dr. Leslie Lam This significant milestone provides a foundation for future implants under early access schemes in Singapore and Australia Angel […]
Virginia Cardiovascular Specialists Deploys PatientKeeper to Enable Providers to Access Patient Records and Capture Charges on Mobile Devices
EHR optimization software streamlines workflow for physicians practicing at Richmond-area HCA Virginia and Bon Secours hospitals WALTHAM, Mass., and RICHMOND, Va., Aug. 18, 2020 /PRNewswire/ — Virginia Cardiovascular Specialists (VCS), a leading cardiology practice in Richmond, VA, has deployed PatientKeeper® to enable its providers to have immediate access to patient records and to enter professional charges, anytime, […]
Northwestern Medicine First in Illinois to Utilize Advanced Imaging System During Heart Rhythm Procedure
System reduces radiation exposure, provides 3D, high-definition images of heart in real time CHICAGO, Aug. 17, 2020 /PRNewswire/ — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first in Illinois to use a new advanced imaging system during cryoablation, a minimally-invasive treatment for atrial fibrillation requiring precise images of the heart. Bradley Knight, […]
Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020
Data presentation will highlight efficacy, safety and tolerability of investigational medicine in patients with hypertriglyceridemia and cardiovascular disease BOSTON and CARLSBAD, Calif., Aug. 18, 2020 /PRNewswire/ — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced that data from the Phase 2 study of AKCEA-APOCIII-LRx will be […]
Cytokinetics Announces Partnership to Improve Prediction of Risk and Outcomes in Hypertrophic Cardiomyopathy
Company Makes Long-term Commitment to Outcomes Research in HCM SOUTH SAN FRANCISCO, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced a $1 million grant and four-year partnership with the HCM Registry (HCMR), a global registry of patients with hypertrophic cardiomyopathy (HCM) focused on improving predictive measures […]
CHF Solutions’ Aquadex Products Granted Federal Supply Schedule Contract
EDEN PRAIRIE, Minn., Aug. 18, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced that its Aquadex™ product line has been added to the Federal Supply Schedule, expanding access to all federal government agencies, […]
New Pilot Study Indicates Niagen® May Reduce Inflammatory Cytokines in Stage D Heart Failure Patients
Niagen® (patented nicotinamide riboside) may reduce production of inflammatory cytokines in pilot study of Stage D heart failure patients LOS ANGELES–(BUSINESS WIRE)–ChromaDex Corp. (NASDAQ:CDXC) today announced the 11th published human trial on its patented NAD-boosting nutrient Niagen®, further highlighting its potential to support cardiovascular health in humans. A NIH funded study […]



